ArrowMark Colorado Holdings LLC 13D and 13G filings for Talis Biomedical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 5:32 pm Sale | 2022-12-31 | 13G | Talis Biomedical Corporation TLIS | ArrowMark Colorado Holdings LLC | 77,268 4.330% | -7,257 (-8.59%) | Filing |
| 2022-09-12 09:03 am Sale | 2021-08-31 | 13G | Talis Biomedical Corporation TLIS | ArrowMark Colorado Holdings LLC | 84,524 4.760% | -253,505 (-75.00%) | Filing |
| 2022-02-14 2:50 pm Sale | 2021-12-31 | 13G | Talis Biomedical Corporation TLIS | ArrowMark Colorado Holdings LLC | 338,030 19.290% | -60,289 (-15.14%) | Filing |
| 2021-04-12 4:20 pm Purchase | 2021-03-31 | 13G | Talis Biomedical Corporation TLIS | ArrowMark Colorado Holdings LLC | 398,319 23.300% | 190,632 (+91.79%) | Filing |
| 2021-03-10 3:03 pm Purchase | 2021-02-28 | 13G | Talis Biomedical Corporation TLIS | ArrowMark Colorado Holdings LLC | 207,687 12.200% | 207,687 (New Position) | Filing |